#AIEye #Podcast 684: #Stocks discussed: (NYSE: $PATH) (NasdaqGM: $IPA) #artificialintelligence
UiPath Announces Strategic Partnership with NCS, and IPA Completes Acquisition of BioStrand
Global #AI in #Military Market to Reach $13.71B by 2028
Vancouver, Kelowna, Delta, BC – April 18, 2022 – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence
Listen to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2022/041822-AI-Eye.mp3
Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/04181PATH-IPA.asp
Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (NYSE:PATH) (NasdaqGM:IPA)
UiPath, Inc. (NYSE:PATH) has announced a strategic partnership with technology services firm NCS for “the deployment of enterprise-grade automation capabilities.” Howie Lau, Managing Partner of Corporate Development and Partnerships, NCS, said:
"The convergence of 5G, IoT, and artificial intelligence (AI) has created new business opportunities for enterprises and consumers. To fully capitalize on this, enterprises need to improve the performance, flexibility, and reliability of their technology. NCS is investing in developing intelligent and automated operating models to deliver rich customer experiences and drive high-impact employee engagement. Through our partnership with UiPath, we are reimagining and simplifying internal processes by integrating automation into our business units and products to offer our clients more intelligent and elevated services for the digital age."
ImmunoPrecise Antibodies, Ltd. (NasdaqGM:IPA) has completed its previously announced acquisition of control over Belgian biotech entities BioStrand BV, BioKey BV, and BioClue BV – henceforth to be collectively referred to as BioStrand. Jennifer Bath, CEO of IPA, explained:
"Uniting BioStrand and IPA reflects the Company’s commitment to acquiring truly transformative technologies that leapfrog traditional competencies driving the development of safe and effective antibody therapies. For several years IPA’s team has scrutinized artificial intelligence (AI) and machine learning technologies, in search of capabilities that don’t simply give a nod to an opaque use of computationally-driven analyses, nor incremental and limited additions to currently existing research tools, but instead change the trajectory of personalized medicines and the philosophy behind what is truly meaningful for the future of AI in the life sciences.”
Global AI in Military Market to Reach $13.71B by 2028
A report published by Vantage Market Research finds that the global AI in Military market is projected to grow from $6.62 billion USD in 2021 to $13.71 billion by 2028, registering a compound annual growth rate (CAGR) of 12.9 percent in the forecast period 2022-28. An excerpt from the report’s description outlines some factors influencing the growth of the market:
The growth of Artificial Intelligence In Military sector is mainly attributed to the growth in the development of Artificial Intelligence integrated systems and the increasing adoption of cloud-based high-performance computers and applications. Moreover, the increase in government initiatives and funding for the defense sector in major countries to advance AI capabilities, and the development of specialized AI chips in the market are projected to fuel the growth of the Artificial Intelligence In Military market in the coming years.
Sam Mowers, Investorideas.com
Read and hear other editions of the AI Eye
For a list of artificial intelligence stocks on Investorideas.com visit here
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Technology stock investor ideas - news, articles, podcasts and stock directories